TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced NSCLC: Phase 2b Results of the TIME trial

John Nemunaitis, et al.
SITC 2015, November 2015 – Abstract available on the SITC website
Download the poster here
Poster Presentation